Reviews1 September 2015
A Systematic Review and Network Meta-analysis of Osteoarthritis Trials
    Author, Article, and Disclosure Information

    Abstract

    Background:

    Placebo controls are essential in evaluating the effectiveness of medical treatments. Although it is unclear whether different placebo interventions for osteoarthritis vary in efficacy, systematic differences would substantially affect interpretation of the results of placebo-controlled trials.

    Objective:

    To evaluate the effects of alternative placebo types on pain outcomes in knee osteoarthritis.

    Data Sources:

    MEDLINE, EMBASE, Web of Science, Google Scholar, and Cochrane Database from inception through 1 June 2015 and unpublished data.

    Study Selection:

    149 randomized trials of adults with knee osteoarthritis that reported pain outcomes and compared widely used pharmaceuticals against oral, intra-articular, topical, and oral plus topical placebos.

    Data Extraction:

    Study data were independently double-extracted; study quality was assessed by using the Cochrane risk of bias tool.

    Data Synthesis:

    Placebo effects that were evaluated by using a network meta-analysis with 4 separate placebo nodes (differential model) showed that intra-articular placebo (effect size, 0.29 [95% credible interval, 0.09 to 0.49]) and topical placebo (effect size, 0.20 [credible interval, 0.02 to 0.38]) had significantly greater effect sizes than did oral placebo. This differential model showed marked differences in the relative efficacies and hierarchy of the active treatments compared with a network model that considered all placebos equivalent. In the model accounting for differential effects, intra-articular and topical therapies were superior to oral treatments in reducing pain. When these differential effects were ignored, oral nonsteroidal anti-inflammatory drugs were superior.

    Limitations:

    Few studies compared different placebos directly. The study could not decisively conclude whether disease severity and co-interventions systematically differed between trials evaluating different placebos.

    Conclusion:

    All placebos are not equal, and some can trigger clinically relevant responses. Differential placebo effects can substantially alter estimates of the relative efficacies of active treatments, an important consideration for the design of clinical trials and interpretation of their results.

    Primary Funding Source:

    Agency for Healthcare Research and Quality.

    References

    • 1. Bijlsma JWWelsing PMThe art of medicine in treating osteoarthritis: I will please [Editorial]. Ann Rheum Dis2008;67:1653-5. [PMID: 19005153] doi:10.1136/ard.2008.097006 CrossrefMedlineGoogle Scholar
    • 2. Koshi EBShort CAPlacebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract2007;7:4-20. [PMID: 17305673] CrossrefMedlineGoogle Scholar
    • 3. Hróbjartsson AGøtzsche PCIs the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med2001;344:1594-602. [PMID: 11372012] CrossrefMedlineGoogle Scholar
    • 4. Wampold BEMinami TTierney SCBaskin TWBhati KSThe placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol2005;61:835-54. [PMID: 15827993] CrossrefMedlineGoogle Scholar
    • 5. Hahn RAThe nocebo phenomenon: concept, evidence, and implications for public health. Prev Med1997;26:607-11. [PMID: 9327466] CrossrefMedlineGoogle Scholar
    • 6. Cipriani ABarbui CSalanti GRendell JBrown RStockton Set alComparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet2011;378:1306-15. [PMID: 21851976] doi:10.1016/S0140-6736(11)60873-8 CrossrefMedlineGoogle Scholar
    • 7. Naudet FMillet BCharlier PReymann JMMaria ASFalissard BWhich placebo to cure depression? A thought-provoking network meta-analysis. BMC Med2013;11:230. [PMID: 24160565] doi:10.1186/1741-7015-11-230 CrossrefMedlineGoogle Scholar
    • 8. Meissner KFässler MRücker GKleijnen JHróbjartsson ASchneider Aet alDifferential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med2013;173:1941-51. [PMID: 24126676] doi:10.1001/jamainternmed.2013.10391 CrossrefMedlineGoogle Scholar
    • 9. Bannuru RRSchmid CHKent DMVaysbrot EEWong JBMcAlindon TEComparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med2015;162:46-54. [PMID: 25560713] doi:10.7326/M14-1231 LinkGoogle Scholar
    • 10. Manyanga TFroese MZarychanski RAbou-Setta AFriesen CTennenhouse Met alPain management with acupuncture in osteoarthritis: a systematic review and meta-analysis. BMC Complement Altern Med2014;14:312. [PMID: 25151529] doi:10.1186/1472-6882-14-312 CrossrefMedlineGoogle Scholar
    • 11. Higgins JPTAltman DGSterne JAAssessing risk of bias in included studies.. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration; 2011. Google Scholar
    • 12. Juhl CLund HRoos EMZhang WChristensen RA hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. Arthritis2012;2012:136245. [PMID: 22792458] doi:10.1155/2012/136245 CrossrefMedlineGoogle Scholar
    • 13. Bannuru RRNatov NSDasi URSchmid CHMcAlindon TETherapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthritis Cartilage2011;19:611-9. [PMID: 21443958] doi:10.1016/j.joca.2010.09.014 CrossrefMedlineGoogle Scholar
    • 14. Cooper HHedges LVThe Hand Book of Research Synthesis. New York: Russell Sage Foundation Publications; 1994. Google Scholar
    • 15. Salanti GIndirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods2012;3:80-97. [PMID: 26062083] doi:10.1002/jrsm.1037 CrossrefMedlineGoogle Scholar
    • 16. Dias SSutton AJAdes AEWelton NJEvidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making2013;33:607-17. [PMID: 23104435] doi:10.1177/0272989X12458724 CrossrefMedlineGoogle Scholar
    • 17. Dias SWelton NJCaldwell DMAdes AEChecking consistency in mixed treatment comparison meta-analysis. Stat Med2010;29:932-44. [PMID: 20213715] doi:10.1002/sim.3767 CrossrefMedlineGoogle Scholar
    • 18. Thorlund KWalter SDJohnston BCFurukawa TAGuyatt GHPooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability. Res Synth Methods2011;2:188-203. [PMID: 26061786] doi:10.1002/jrsm.46 CrossrefMedlineGoogle Scholar
    • 19. Pham Tvan der Heijde DAltman RDAnderson JJBellamy NHochberg Met alOMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage2004;12:389-99. [PMID: 15094138] CrossrefMedlineGoogle Scholar
    • 20. Dias SSutton AJWelton NJAdes AEEvidence synthesis for decision making 3: heterogeneity—subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making2013;33:618-40. [PMID: 23804507] doi:10.1177/0272989X13485157 CrossrefMedlineGoogle Scholar
    • 21. Conaghan PGDickson JBolten WCevc GRother MA multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford)2013;52:1303-12. [PMID: 23542612] doi:10.1093/rheumatology/ket133 CrossrefMedlineGoogle Scholar
    • 22. Zhang WRobertson JJones ACDieppe PADoherty MThe placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis2008;67:1716-23. [PMID: 18541604] doi:10.1136/ard.2008.092015 CrossrefMedlineGoogle Scholar
    • 23. Morison RAWoodmansey AYoung AJPlacebo responses in an arthritis trial. Ann Rheum Dis1961;20:179-85. [PMID: 13772684] CrossrefMedlineGoogle Scholar
    • 24. Traut EFPassarelli EWPlacebos in the treatment of rheumatoid arthritis and other rheumatic conditions. Ann Rheum Dis1957;16:18-22. [PMID: 13412002] CrossrefMedlineGoogle Scholar
    • 25. Kaptchuk TJStason WBDavis RBLegedza ARSchnyer RNKerr CEet alSham device v inert pill: randomised controlled trial of two placebo treatments. BMJ2006;332:391-7. [PMID: 16452103] CrossrefMedlineGoogle Scholar
    • 26. Grenfell RFBriggs AHHolland WCA double-blind study of the treatment of hypertension. JAMA1961;176:124-8. [PMID: 13708477] CrossrefMedlineGoogle Scholar
    • 27. National Clinical Guideline Centre. Osteoarthritis. Care and management in adults. London, United Kingdom: National Institute for Health and Care Excellence; 2014. Google Scholar
    • 28. Hochberg MCAltman RDApril KTBenkhalti MGuyatt GMcGowan Jet alAmerican College of RheumatologyAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken)2012;64:465-74. [PMID: 22563589] CrossrefMedlineGoogle Scholar
    • 29. McAlindon TEBannuru RRSullivan MCArden NKBerenbaum FBierma-Zeinstra SMet alOARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage2014;22:363-88. [PMID: 24462672] doi:10.1016/j.joca.2014.01.003 CrossrefMedlineGoogle Scholar
    • 30. Jonas WBReframing placebo in research and practice. Philos Trans R Soc Lond B Biol Sci2011;366:1896-904. [PMID: 21576147] doi:10.1098/rstb.2010.0405 CrossrefMedlineGoogle Scholar
    • 31. Finniss DGKaptchuk TJMiller FBenedetti FBiological, clinical, and ethical advances of placebo effects. Lancet2010;375:686-95. [PMID: 20171404] doi:10.1016/S0140-6736(09)61706-2 CrossrefMedlineGoogle Scholar
    • 32. Thomas KBGeneral practice consultations: is there any point in being positive? Br Med J (Clin Res Ed)1987;294:1200-2. [PMID: 3109581] CrossrefMedlineGoogle Scholar
    • 33. Miller FGRosenstein DLThe nature and power of the placebo effect. J Clin Epidemiol2006;59:331-5. [PMID: 16549251] CrossrefMedlineGoogle Scholar
    • 34. Case JPBaliunas AJBlock JALack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med2003;163:169-78. [PMID: 12546607] CrossrefMedlineGoogle Scholar
    • 35. Miceli-Richard CLe Bars MSchmidely NDougados MParacetamol in osteoarthritis of the knee. Ann Rheum Dis2004;63:923-30. [PMID: 15249319] CrossrefMedlineGoogle Scholar
    • 36. Pincus TKoch GLei HMangal BSokka TMoskowitz Ret alPatient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis2004;63:931-9. [PMID: 15082468] CrossrefMedlineGoogle Scholar
    • 37. Altman RDZinsenheim JRTemple ARSchweinle JEThree-month efficacy and safety of acetaminophen extended-release for osteoarthritis pain of the hip or knee: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage2007;15:454-61. [PMID: 17142063] CrossrefMedlineGoogle Scholar
    • 38. Herrero-Beaumont GIvorra JADel Carmen Trabado MBlanco FJBenito PMartín-Mola Eet alGlucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum2007;56:555-67. [PMID: 17265490] CrossrefMedlineGoogle Scholar
    • 39. Yocum DFleischmann RDalgin PCaldwell JHall DRoszko PSafety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis InvestigatorsArch Intern Med. 2000;160:2947-54. [PMID: 11041902] MedlineGoogle Scholar
    • 40. Ghosh SPaul SDas NBhattacharyya TKA study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis. J Indian Med Assoc2007;105:260-2. [PMID: 17915794] MedlineGoogle Scholar
    • 41. Davies GMWatson DJBellamy NComparison of the responsiveness and relative effect size of the western Ontario and McMaster Universities Osteoarthritis Index and the short-form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients. Arthritis Care Res1999;12:172-9. [PMID: 10513507] CrossrefMedlineGoogle Scholar
    • 42. Day RMorrison BLuza ACastaneda OStrusberg ANahir Met alA randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group. Arch Intern Med2000;160:1781-7. [PMID: 10871971] CrossrefMedlineGoogle Scholar
    • 43. Saag Kvan der Heijde DFisher CSamara ADeTora LBolognese Jet alRofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies GroupArch Fam Med. 2000;9:1124-34. [PMID: 11115219] MedlineGoogle Scholar
    • 44. Wiesenhutter CWBoice JAKo ASheldon EAMurphy FTWittmer BAet alProtocol 071 Study GroupEvaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial. Mayo Clin Proc2005;80:470-9. [PMID: 15819283] CrossrefMedlineGoogle Scholar
    • 45. Puopolo ABoice JAFidelholtz JLLittlejohn TWMiranda PBerrocal Aet alA randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis. Osteoarthritis Cartilage2007;15:1348-56. [PMID: 17631392] CrossrefMedlineGoogle Scholar
    • 46. Dore RBallard IConstantine GMcDonald PEfficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study. Clin Ther1995;17:656-66. [PMID: 8565029] CrossrefMedlineGoogle Scholar
    • 47. Fleischmann RMFlint KConstantine GKolecki BA double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group. Clin Ther1997;19:642-55. [PMID: 9377610] CrossrefMedlineGoogle Scholar
    • 48. Bensen WGFiechtner JJMcMillen JIZhao WWYu SSWoods EMet alTreatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc1999;74:1095-105. [PMID: 10560596] CrossrefMedlineGoogle Scholar
    • 49. Zhao SZMcMillen JIMarkenson JADedhiya SDZhao WWOsterhaus JTet alEvaluation of the functional status aspects j of health-related quality of life of patients with osteoarthritis treated with celecoxib. Pharmacotherapy1999;19:1269-78. [PMID: 10555933] CrossrefMedlineGoogle Scholar
    • 50. Kivitz AEisen GZhao WWBevirt TRecker DPRandomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. J Fam Pract2002;51:530-7. [PMID: 12100776] MedlineGoogle Scholar
    • 51. Lohmander LSMcKeith DSvensson OMalmenäs MBolin LKalla Aet alSTAR Multinational Study GroupA randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis. Ann Rheum Dis2005;64:449-56. [PMID: 15345500] CrossrefMedlineGoogle Scholar
    • 52. Svensson OMalmenäs MFajutrao LRoos EMLohmander LSGreater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36. Ann Rheum Dis2006;65:781-4. [PMID: 16269428] CrossrefMedlineGoogle Scholar
    • 53. Schnitzer TJKivitz AJLipetz RSSanders NHee AComparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of osteoarthritis of the knee. Arthritis Rheum2005;53:827-37. [PMID: 16342089] CrossrefMedlineGoogle Scholar
    • 54. Reginster JYMalmstrom KMehta ABergman GKo ATCurtis SPet alEvaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Ann Rheum Dis2007;66:945-51. [PMID: 17142385] CrossrefMedlineGoogle Scholar
    • 55. Leung ATMalmstrom KGallacher AESarembock BPoor GBeaulieu Aet alEfficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial. Curr Med Res Opin2002;18:49-58. [PMID: 12017209] CrossrefMedlineGoogle Scholar
    • 56. Schnitzer TJKivitz AFrayssinet HDuquesroix BEfficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study. Osteoarthritis Cartilage2010;18:629-39. [PMID: 20202489] doi:10.1016/j.joca.2009.12.013 CrossrefMedlineGoogle Scholar
    • 57. Schnitzer TJHochberg MCMarrero CEDuquesroix BFrayssinet HBeekman MEfficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study. Semin Arthritis Rheum2011;40:285-97. [PMID: 20828790] doi:10.1016/j.semarthrit.2010.06.002 CrossrefMedlineGoogle Scholar
    • 58. Hochberg MCFort JGSvensson OHwang CSostek MFixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials. Curr Med Res Opin2011;27:1243-53. [PMID: 21524238] doi:10.1185/03007995.2011.580340 CrossrefMedlineGoogle Scholar
    • 59. McKenna FBorenstein DWendt HWallemark CLefkowith JBGeis GSCelecoxib versus diclofenac in the management of osteoarthritis of the knee. Scand J Rheumatol2001;30:11-8. [PMID: 11252686] CrossrefMedlineGoogle Scholar
    • 60. Essex MNBhadra PSands GHEfficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis of the knee: a randomized, double-blind, double-dummy trial. J Int Med Res2012;40:1357-70. [PMID: 22971487] CrossrefMedlineGoogle Scholar
    • 61. Essex MNO'Connell MBhadra Brown PResponse to nonsteroidal anti-inflammatory drugs in African Americans with osteoarthritis of the knee. J Int Med Res2012;40:2251-66. [PMID: 23321182] CrossrefMedlineGoogle Scholar
    • 62. Essex MNO'Connell MABehar RBrown PBResponse to nonsteroidal anti-inflammatory agents in Asian patients with osteoarthritis of the knee. Osteoarthritis Cartilage2013;21 (Suppl):S252-3. Google Scholar
    • 63. Essex MNBehar RO'Connell MABrown PBEfficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis. Int J Gen Med2014;7:227-35. [PMID: 24876792] doi:10.2147/IJGM.S61297 CrossrefMedlineGoogle Scholar
    • 64. Williams GWEttlinger RERuderman EMHubbard RCLonien MEYu SSet alTreatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trial. J Clin Rheumatol2000;6:65-74. [PMID: 19078452] CrossrefMedlineGoogle Scholar
    • 65. McKenna FWeaver AFiechtner JJBello AEFort JGCOX-2 specific inhibitors in the management of osteoarthritis of the knee: a placebo-controlled, randomized, double-blind study. J Clin Rheumatol2001;7:151-9. [PMID: 17039120] CrossrefMedlineGoogle Scholar
    • 66. Williams GWHubbard RCYu SSZhao WGeis GSComparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee. Clin Ther2001;23:213-27. [PMID: 11293555] CrossrefMedlineGoogle Scholar
    • 67. Gibofsky AWilliams GWMcKenna FFort JGComparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial. Arthritis Rheum2003;48:3102-11. [PMID: 14613272] CrossrefMedlineGoogle Scholar
    • 68. Tannenbaum HBerenbaum FReginster JYZacher JRobinson JPoor Get alLumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis2004;63:1419-26. [PMID: 15020310] CrossrefMedlineGoogle Scholar
    • 69. Fleischmann RSheldon EMaldonado-Cocco JDutta DYu SSloan VSLumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib. Clin Rheumatol2006;25:42-53. [PMID: 16132165] CrossrefMedlineGoogle Scholar
    • 70. Lehmann RBrzosko MKopsa PNischik RKreisse AThurston Het alEfficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib. Curr Med Res Opin2005;21:517-26. [PMID: 15899100] CrossrefMedlineGoogle Scholar
    • 71. Sheldon EBeaulieu APaster ZDutta DYu SSloan VSEfficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. Clin Ther2005;27:64-77. [PMID: 15763607] CrossrefMedlineGoogle Scholar
    • 72. Birbara CRuoff GSheldon EValenzuela CRodgers APetruschke RAet alEfficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Curr Med Res Opin2006;22:199-210. [PMID: 16393445] CrossrefMedlineGoogle Scholar
    • 73. Clegg DOReda DJHarris CLKlein MAO'Dell JRHooper MMet alGlucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med2006;354:795-808. [PMID: 16495392] CrossrefMedlineGoogle Scholar
    • 74. Bingham CO 3rdSebba AIRubin BRRuoff GEKremer JBird Set alEfficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford)2007;46:496-507. [PMID: 16936327] CrossrefMedlineGoogle Scholar
    • 75. Boswell DJOstergaard KPhilipson RSHodge RABlum DBrown JCet alEvaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies. Medscape J Med2008;10:259. [PMID: 19099009] MedlineGoogle Scholar
    • 76. Asmus MJEssex MNBrown PBMallen SREfficacy and tolerability of celecoxib in patients with osteoarthritis who previously did not respond to or did not tolerate naproxen and ibuprofen: results from 2 identically designed randomized trials. Osteoarthritis Cartilage2013;21(Suppl):S253. CrossrefGoogle Scholar
    • 77. Bradley JDBrandt KDKatz BPKalasinski LARyan SIComparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med1991;325:87-91. [PMID: 2052056] CrossrefMedlineGoogle Scholar
    • 78. Williams HJWard JREgger MJNeuner RBrooks RHClegg DOet alComparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum1993;36:1196-206. [PMID: 8216413] CrossrefMedlineGoogle Scholar
    • 79. Pincus TKoch GGSokka TLefkowith JWolfe FJordan JMet alA randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum2001;44:1587-98. [PMID: 11465710] CrossrefMedlineGoogle Scholar
    • 80. Doherty MHawkey CGoulder MGibb IHill NAspley Set alA randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Ann Rheum Dis2011;70:1534-41. [PMID: 21804100] doi:10.1136/ard.2011.154047 CrossrefMedlineGoogle Scholar
    • 81. Geba GPWeaver ALPolis ABDixon MESchnitzer TJVioxx, Acetaminophen, Celecoxib Trial (VACT) GroupEfficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA2002;287:64-71. [PMID: 11754710] CrossrefMedlineGoogle Scholar
    • 82. Schnitzer TJWeaver ALPolis ABPetruschke RAGeba GPVACT-1 and VACT-2 (Protocols 106 and 150) Study GroupsEfficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studiesJ Rheumatol. 2005;32:1093-105. [PMID: 15940774] MedlineGoogle Scholar
    • 83. Adams MEAtkinson MHLussier AJSchulz JISiminovitch KAWade JPet alThe role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage1995;3:213-25. [PMID: 8689457] CrossrefMedlineGoogle Scholar
    • 84. Altman RDMoskowitz RIntraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol1998;25:2203-12. [PMID: 9818665] MedlineGoogle Scholar
    • 85. Dickson DJHosie GEnglish JRA double blind, placebo-controlled comparison of hylan GF-20 against diclofenac in knee OA. J Clin Res2001;4:41-52. Google Scholar
    • 86. Petrella RJDiSilvestro MDHildebrand CEffects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med2002;162:292-8. [PMID: 11822921] CrossrefMedlineGoogle Scholar
    • 87. Ishijima MNakamura TShimizu KHayashi KKikuchi HSoen Set alResearch Group of Cartilage MetabolismIntra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial. Arthritis Res Ther2014;16:R18. [PMID: 24443804] doi:10.1186/ar4446 CrossrefMedlineGoogle Scholar
    • 88. Novartis NA randomized, double blind, placebo and Naproxen controlled, multi-center, study to determine the safety, tolerability, pharmacokinetics and effect on pain of a single intra-articular administration of Canakinumab in patients with osteoarthritis in the knee. [CACZ885C2201]. Novartis Clinical Trial Results Database2012. Google Scholar
    • 89. Leardini GFranceschini MMattara LBruno RPebrellini AIntra-articular sodium hyaluronate (Hyalgan) in gonarthrosis: a controlled study comparing methylprednisolone acetate. Clin Trials J1987;24:341-50. Google Scholar
    • 90. Leardini GMattara LFranceschini MPerbellini AIntra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetateClin Exp Rheumatol. 1991;9:375-81. [PMID: 1934686] MedlineGoogle Scholar
    • 91. Pietrogrande VMelanotte PLD'Agnolo BUlivi MBenigni GATurchetto LHtiluronic acid versus methylprednisolone intra-articularly injected for treatment of osteoarthritis of the knee. Curr Ther Re1991;50:691-701. Google Scholar
    • 92. Jones ACPattrick MDoherty SDoherty MIntra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage1995;3:269-73. [PMID: 8689462] CrossrefMedlineGoogle Scholar
    • 93. Tekeoglu IAdak BGoksoy TTosun NEffects of intra-articular injection of sodium hyaluronate (Orthovisc) and betamethasone on osteoarthritis of the knee. J Rheum Med Rehab1998;9 4 220-224. Google Scholar
    • 94. Frizziero LPasquali Ronchetti IIntra-articular treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. J Orthop Traumatol2002;3:89-96. CrossrefGoogle Scholar
    • 95. Tasciotaoglu FOner CEfficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol2003;22:112-7. [PMID: 12740675] CrossrefMedlineGoogle Scholar
    • 96. Caborn DRush JLanzer WParenti DMurray CSynvisc 901 Study GroupA randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol2004;31:333-43. [PMID: 14760806] MedlineGoogle Scholar
    • 97. Skwara APonelis RTibesku CORosenbaum DFuchs-Winkelmann SGait patterns after intraarticular treatment of patients with osteoarthritis of the knee—hyaluronan versus triamcinolone: a prospective, randomized, doubleblind, monocentric study. Eur J Med Res2009;14:157-64. [PMID: 19380288] CrossrefMedlineGoogle Scholar
    • 98. Skwara APeterlein CDTibesku CORosenbaum DFuchs-Winkelmann SChanges of gait patterns and muscle activity after intraarticular treatment of patients with osteoarthritis of the knee: a prospective, randomised, doubleblind study. Knee2009;16:466-72. [PMID: 19362003] doi:10.1016/j.knee.2009.03.003 CrossrefMedlineGoogle Scholar
    • 99. Shimizu MHiguchi HTakagishi KShinozaki TKobayashi TClinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid. J Orthop Sci2010;15:51-6. [PMID: 20151251] doi:10.1007/s00776-009-1421-0 CrossrefMedlineGoogle Scholar
    • 100. Housman LArden NSchnitzer TJet alIntra-articular hylastan versus steroid for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc2014;22:1684-92. CrossrefMedlineGoogle Scholar
    • 101. Leighton RAkermark CTherrien RRichardson JBAndersson MTodman MGet alDUROLANE Study GroupNASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage2014;22:17-25. [PMID: 24185114] doi:10.1016/j.joca.2013.10.009 CrossrefMedlineGoogle Scholar
    • 102. Shichikawa KIgarashi MSugawara SIwasaki YClinical evaluation of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee—a multi-center well controlled comparative study. Jpn J Clin Pharmacol Therapeut1983;14:545-58. CrossrefGoogle Scholar
    • 103. Shichikawa KMaeda AOgawa N[Clinical evaluation of sodium hyaluronate in the treatment of osteoarthritis of the knee]. Ryumachi1983;23:280-90. [PMID: 6364389] MedlineGoogle Scholar
    • 104. Bragantini ACassini MDe Bastiani GPerbellini AControlled single-blind trial of intra-articulary injected hyaluronic acid (Hyalgan®) in osteoarthritis of the knee. Clin Trials J1987;24:333-40. Google Scholar
    • 105. Grecomoro GMartorana UDi Marco CIntra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica1987;5:137-41. [PMID: 3310017] MedlineGoogle Scholar
    • 106. Dixon ASJacoby RKBerry HHamilton EBClinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin1988;11:205-13. [PMID: 3063436] CrossrefMedlineGoogle Scholar
    • 107. Russell IJ MJLawrence VALessard JABriggs BTMay GSA randomized placebo (PL) and no-intervention (NI) controlled, trial of intra-articular (IA) 1% sodium hyaluronate (HA) in the treatment of knee osteoarthritis (OA). Arthritis Rheum1992;(35 Suppl):S132. Google Scholar
    • 108. Dougados MNguyen MListrat VAmor BHigh molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage1993;1:97-103. [PMID: 8886085] CrossrefMedlineGoogle Scholar
    • 109. Moreland LWArnold WJSaway ASavory CSikes DEfficacy and safety of intra-articular Hylan G-F20 (Synvisc®), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee. Arthritis Rheum1993;36:S165. Google Scholar
    • 110. Puhl WBernau AGreiling HKöpcke WPförringer WSteck KJet alIntra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage1993;1:233-41. [PMID: 15449510] CrossrefMedlineGoogle Scholar
    • 111. Cohen MAShiroky JBBallachey MLNeville CEsdaile JMDouble-blind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee. Arthritis Rheum1994;37(Suppl):R31. Google Scholar
    • 112. Creamer PSharif MGeorge EMeadows KCushnaghan JShinmei Met alIntra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage1994;2:133-40. [PMID: 11548229] CrossrefMedlineGoogle Scholar
    • 113. Dahlberg LLohmander LSRyd LIntraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum1994;37:521-8. [PMID: 8147929] CrossrefMedlineGoogle Scholar
    • 114. Henderson EBSmith ECPegley FBlake DRIntra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis1994;53:529-34. [PMID: 7944639] CrossrefMedlineGoogle Scholar
    • 115. Scale DWobig MWolpert WViscosupplementation of osteoarthritic knees with hylan: A treatment schedule study. Curr Therap Res Clin Exp1994;55:220-32. CrossrefGoogle Scholar
    • 116. Carrabba MParesce EAngelini MRe KATorchiana EEMPerbellini AThe safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm1995;15:25-31. Google Scholar
    • 117. Corrado EMPeluso GFGigliotti Set alThe effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm1995;15:47-56. Google Scholar
    • 118. Sodium Hyaluronate (SUPARTZ) PMA P980044: Summary of Safety and Effectiveness Data. 24 January 2001. Accessed at www.accessdata.fda.gov/cdrh_docs/pdf/P980044b.pdf on 20 September 2013. Google Scholar
    • 119. Formiguera Sala SEsteve de Miguel RIntra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflamm1995;15:33-8. Google Scholar
    • 120. Lohmander LSDalén NEnglund GHämäläinen MJensen EMKarlsson Ket alIntra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis1996;55:424-31. [PMID: 8774159] CrossrefMedlineGoogle Scholar
    • 121. Wu JJShih LYHsu HCChen THThe double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei)1997;59:99-106. [PMID: 9175299] MedlineGoogle Scholar
    • 122. Wobig MDickhut AMaier RVetter GViscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther1998;20:410-23. [PMID: 9663358] CrossrefMedlineGoogle Scholar
    • 123. Huskisson ECDonnelly SHyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford)1999;38:602-7. [PMID: 10461471] CrossrefMedlineGoogle Scholar
    • 124. Brandt KDBlock JAMichalski JPMoreland LWCaldwell JRLavin PTEfficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res2001:130-43. [PMID: 11302304] CrossrefMedlineGoogle Scholar
    • 125. Bunyaratavej NChan KMSubramanian NTreatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai2001;84 Suppl 2:S576-81. [PMID: 11853284] MedlineGoogle Scholar
    • 126. Tamir ERobinson DKoren RAgar GHalperin NIntra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol2001;19:265-70. [PMID: 11407078] MedlineGoogle Scholar
    • 127. Karlsson JSjögren LSLohmander LSComparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford)2002;41:1240-8. [PMID: 12421996] CrossrefMedlineGoogle Scholar
    • 128. Saravanan VMTStobbs DDaymond TJInflammatory effusion after viscosupplementation with Hylan G-F 20 [Abstract 336]. Rheumatology2002;41 Suppl 1 121. MedlineGoogle Scholar
    • 129. Jubb RWPiva SBeinat LDacre JGishen PA one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract2003;57:467-74. [PMID: 12918884] MedlineGoogle Scholar
    • 130. Tsai CLChang CCChen SCBeinat LPiva STreatment of knee osteoarthritis in Asian population with an intra-articular hyaluronan of MW 500-730 KDa [Abstract P333]. Osteoarthritis Cartilage2003;11 Suppl A 119. Google Scholar
    • 131. Altman RDAkermark CBeaulieu ADSchnitzer TDurolane International Study GroupEfficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage2004;12:642-9. [PMID: 15262244] CrossrefMedlineGoogle Scholar
    • 132. Day RBrooks PConaghan PGPetersen MMulticenter Trial GroupA double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol2004;31:775-82. MedlineGoogle Scholar
    • 133. Pham TLe Henanff ARavaud PDieppe PPaolozzi LDougados MEvaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis2004;63:1611-7. [PMID: 15331394] CrossrefMedlineGoogle Scholar
    • 134. Cubukçu DArdiç FKarabulut NTopuz OHylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol2005;24:336-41. [PMID: 15599642] CrossrefMedlineGoogle Scholar
    • 135. Neustadt DCaldwell JBell MWade JGimbel JClinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol2005;32:1928-36. [PMID: 16206349] MedlineGoogle Scholar
    • 136. Rolf CGEngstrom BOhrvik JValentin ALilja BLevine DWA comparative study of the efficacy and safety of hyaluronan viscosupplements and placebo in patients with symptomatic and arthroscopy-verified cartilage pathology. J Drug Assess2005;8:183-200. Google Scholar
    • 137. Sezgin MDemirel ACKaraca COrtancil OUlkar GBKanik Aet alDoes hyaluronan affect inflammatory cytokines in knee osteoarthritis? Rheumatol Int2005;25:264-9. [PMID: 14999424] CrossrefMedlineGoogle Scholar
    • 138. Kotevoglu NIyibozkurt PCHiz OToktas HKuran BA prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int2006;26:325-30. [PMID: 15959784] CrossrefMedlineGoogle Scholar
    • 139. Petrella RJPetrella MA prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol2006;33:951-6. [PMID: 16652426] MedlineGoogle Scholar
    • 140. Blanco FJFernández-Sueiro JLPinto-Tasende JAet alIntra-articular hyaluronan treatment of patients with knee osteoarthritis waiting for replacement surgery. Open Arthritis J2008;1:1-7. CrossrefGoogle Scholar
    • 141. Lundsgaard CDufour NFallentin EWinkel PGluud CIntra-articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol2008;37:142-50. [PMID: 18415773] doi:10.1080/03009740701813103 CrossrefMedlineGoogle Scholar
    • 142. Petrella RJCogliano ADecaria JCombining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Clin Rheumatol2008;27:975-81. [PMID: 18204873] doi:10.1007/s10067-007-0834-4 CrossrefMedlineGoogle Scholar
    • 143. Sanofi-Aventis. A double blind, randomized trial of intra-articular injections of 20 mg of HYALGAN for the treatment of knee pain due to osteoarthritis [NCT00130468]. 2008. Accessed at http://en.sanofi.com/img/content/study/L_9385_summary.pdf on 8 July 2015. Google Scholar
    • 144. Altman RDRosen JEBloch DAHatoum HTKorner PA double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum2009;39:1-9. [PMID: 19539353] doi:10.1016/j.semarthrit.2009.04.001 CrossrefMedlineGoogle Scholar
    • 145. Baltzer AWMoser CJansen SAKrauspe RAutologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage2009;17:152-60. [PMID: 18674932] doi:10.1016/j.joca.2008.06.014 CrossrefMedlineGoogle Scholar
    • 146. Diracoglu DVural MBaskent ADikici FAksoy CThe effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis. J Back Musculoskelet Rehabil2009;22:1-9. [PMID: 20023357] doi:10.3233/BMR-2009-0207 CrossrefMedlineGoogle Scholar
    • 147. Chevalier XJerosch JGoupille Pvan Dijk NLuyten FPScott DLet alSingle, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis2010;69:113-9. [PMID: 19304567] doi:10.1136/ard.2008.094623 CrossrefMedlineGoogle Scholar
    • 148. Jørgensen AStengaard-Pedersen KSimonsen OPfeiffer-Jensen MEriksen CBliddal Het alIntra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis2010;69:1097-102. [PMID: 20447955] doi:10.1136/ard.2009.118042 CrossrefMedlineGoogle Scholar
    • 149. Kul-Panza EBerker NIs hyaluronate sodium effective in the management of knee osteoarthritis? A placebo-controlled double-blind study. Minerva Med2010;101:63-72. [PMID: 20467406] MedlineGoogle Scholar
    • 150. Huang TLChang CCLee CHChen SCLai CHTsai CLIntra-articular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord2011;12:221. [PMID: 21978211] doi:10.1186/1471-2474-12-221 CrossrefMedlineGoogle Scholar
    • 151. Navarro-Sarabia FCoronel PCollantes ENavarro FJde la Serna ARNaranjo Aet alAMELIA study groupA 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis2011;70:1957-62. [PMID: 21852252] doi:10.1136/ard.2011.152017 CrossrefMedlineGoogle Scholar
    • 152. DeCaria JEMontero-Odasso MWolfe DChesworth BMPetrella RJThe effect of intra-articular hyaluronic acid treatment on gait velocity in older knee osteoarthritis patients: a randomized, controlled study. Arch Gerontol Geriatr2012;55:310-5. [PMID: 22169699] doi:10.1016/j.archger.2011.11.007 CrossrefMedlineGoogle Scholar
    • 153. Ferring Pharmaceuticals. A 26 week, double-blind, randomized, placebo-controlled study of the efficacy and safety of single intra-articular injection 1.2% sodium hyaluronate for treatment of painful osteoarthritis of the knee, with optional 26-week open-label safety extension (NCT00988091) Last updated 13 June 2012 Accessed at https://clinicaltrials.gov/ct2/show/NCT00988091?term=NCT00988091&rank=1 on 12 May 2015. Google Scholar
    • 154. Kosuwon WSirichatiwapee WVisanuyotin TJeeravipoolvarn PLaupattarakasem WDetermination of cartilage volume using MRI in patients with knee osteoarthritis: efficacy study of 25 milligrams of sodium hyaluronate (2.5 Ml) versus placebo. Clin Exp Pharmacol2012;2 2 1. CrossrefGoogle Scholar
    • 155. Strand VBaraf HSLavin PTLim SHosokawa HA multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis Cartilage2012;20:350-6. [PMID: 22342928] doi:10.1016/j.joca.2012.01.013 CrossrefMedlineGoogle Scholar
    • 156. Arden NKÅkermark CAndersson MTodman MGAltman RDA randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis. Curr Med Res Opin2014;30:279-86. [PMID: 24168077] doi:10.1185/03007995.2013.855631 CrossrefMedlineGoogle Scholar
    • 157. van der Weegen WWullems JABos ENoten Hvan Drumpt RANo difference between intra-articular injection of hyaluronic Acid and placebo for mild to moderate knee osteoarthritis: a randomized, controlled, double-blind trial. J Arthroplasty2015;30:754-7. [PMID: 25548079] doi:10.1016/j.arth.2014.12.012 CrossrefMedlineGoogle Scholar
    • 158. Friedman DMMoore METhe efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol1980;7:850-6. [PMID: 7009857] MedlineGoogle Scholar
    • 159. Gaffney KLedingham JPerry JDIntra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis1995;54:379-81. [PMID: 7794044] CrossrefMedlineGoogle Scholar
    • 160. Jones ADoherty MIntra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis1996;55:829-32. [PMID: 8976640] CrossrefMedlineGoogle Scholar
    • 161. Ravaud PMoulinier LGiraudeau BAyral XGuerin CNoel Eet alEffects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum1999;42:475-82. [PMID: 10088770] CrossrefMedlineGoogle Scholar
    • 162. Raynauld JPBuckland-Wright CWard RChoquette DHaraoui BMartel-Pelletier Jet alSafety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum2003;48:370-7. [PMID: 12571845] CrossrefMedlineGoogle Scholar
    • 163. Chao JWu CSun BHose MKQuan AHughes THet alInflammatory characteristics on ultrasound predict poorer long-term response to intraarticular corticosteroid injections in knee osteoarthritis. J Rheumatol2010;37:650-5. [PMID: 20080918] doi:10.3899/jrheum.090575 CrossrefMedlineGoogle Scholar
    • 164. Yavuz USökücü SAlbayrak AOztürk KEfficacy comparisons of the intraarticular steroidal agents in the patients with knee osteoarthritis. Rheumatol Int2012;32:3391-6. [PMID: 22057944] doi:10.1007/s00296-011-2188-0 CrossrefMedlineGoogle Scholar
    • 165. Ottillinger BGömör BMichel BAPavelka KBeck WElsasser UEfficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage2001;9:273-80. [PMID: 11300751] CrossrefMedlineGoogle Scholar
    • 166. Bookman AAWilliams KSShainhouse JZEffect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ2004;171:333-8. [PMID: 15313991] CrossrefMedlineGoogle Scholar
    • 167. Roth SHShainhouse JZEfficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med2004;164:2017-23. [PMID: 15477437] CrossrefMedlineGoogle Scholar
    • 168. Tugwell PSWells GAShainhouse JZEquivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol2004;31:2002-12. [PMID: 15468367] MedlineGoogle Scholar
    • 169. Baer PAThomas LMShainhouse ZTreatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord2005;6:44. [PMID: 16086839] CrossrefMedlineGoogle Scholar
    • 170. Baraf HSGloth FMBarthel HRGold MSAltman RDSafety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging2011;28:27-40. [PMID: 21174485] doi:10.2165/11584880-000000000-00000 CrossrefMedlineGoogle Scholar
    • 171. Baraf HSGold MSClark MBAltman RDSafety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. Phys Sportsmed2010;38:19-28. [PMID: 20631460] doi:10.3810/psm.2010.06.1779 CrossrefMedlineGoogle Scholar
    • 172. Barthel HRHaselwood DLongley SGold MSAltman RDRandomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum2009;39:203-12. [PMID: 19932833] doi:10.1016/j.semarthrit.2009.09.002 CrossrefMedlineGoogle Scholar
    • 173. Conaghan PGDickson JBolten WCevc GRother MA multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford)2013;52:1303-12. [PMID: 23542612] doi:10.1093/rheumatology/ket133 CrossrefMedlineGoogle Scholar
    • 174. Kneer WRother MMazgareanu SSeidel EJEuropean IDEA-033 study groupA 12-week randomized study of topical therapy with three dosages of ketoprofen in Transfersome gel (IDEA-033) compared with the ketoprofen-free vehicle (TDT 064), in patients with osteoarthritis of the knee. J Pain Res2013;6:743-53. [PMID: 24187510] doi:10.2147/JPR.S51054 CrossrefMedlineGoogle Scholar
    • 175. Rother MConaghan PGA randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J Rheumatol2013;40:1742-8. [PMID: 23996292] doi:10.3899/jrheum.130192 CrossrefMedlineGoogle Scholar
    • 176. Sandelin JHarilainen ACrone HHamberg PForsskåhl BTamelander GLocal NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol1997;26:287-92. [PMID: 9310109] CrossrefMedlineGoogle Scholar
    • 177. Rother MLavins BJKneer WLehnhardt KSeidel EJMazgareanu SEfficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann Rheum Dis2007;66:1178-83. [PMID: 17363401] CrossrefMedlineGoogle Scholar
    • 178. Simon LSGrierson LMNaseer ZBookman AAZev Shainhouse JEfficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain2009;143:238-45. [PMID: 19380203] doi:10.1016/j.pain.2009.03.008 CrossrefMedlineGoogle Scholar